Last reviewed · How we verify
NCT06349603
Physiotherapy Approach for Susac Syndrome
trial in Susac Syndrome in 1 participant. Completed in 6 April 2023.
1 April 2023
Quick facts
| Lead sponsor | Rehabilitation Centre Zivot |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1 |
| Start date | 13 February 2023 |
| Primary completion | 1 April 2023 |
| Estimated completion | 6 April 2023 |
| Sites | 1 location across Bosnia and Herzegovina |
Conditions studied
- Susac Syndrome — all drugs for Susac Syndrome →
Sponsor
Rehabilitation Centre Zivot
Who can join
Eligibility, any sex, with Susac Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Susac's syndrome is a rare autoimmune disorder characterised by a triad of encephalopathy (brain dysfunction), branch retinal artery occlusion (loss of vision) and sensorineural hearing loss. This study presents the case of a patient undergoing intensive physiotherapy intervention following an injury, focusing on assessments such as volume and range of motion measurements, manual muscle tests, and pain intensity evaluations using various scales.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06349603
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Rehabilitation Centre Zivot trials
Trials by the same sponsor.
- NCT06645262 — First-degree Ankle Sprains · recruiting
- NCT06675006 — Comparing Bowen Therapy With Ice to Medical Massage for Acute Ankle Sprain · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06349603 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rehabilitation Centre Zivot
- Last refreshed: 5 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06349603.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing